Overview

Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of repeated doses of oral delafloxacin on the pharmacokinetic (PK) profile of a single oral dose of midazolam.
Phase:
Phase 1
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Fluoroquinolones
Midazolam